The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Prenatal And Newborn Genetic Testing Market Expected To Reach Based On Its 2026 Value?
The prenatal and newborn genetic testing market has seen rapid expansion in recent years. It is forecast to grow from $7.6 billion in 2025 to $8.51 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.0%. Historically, this growth can be linked to heightened awareness of genetic disorders, the enlargement of maternal and neonatal healthcare services, an increase in institutional screening programs, the widespread availability of diagnostic laboratories, and enhancements in the accuracy of genetic testing.
The market size for prenatal and newborn genetic testing is projected to experience swift expansion in the coming years. This market is anticipated to reach $13.65 billion by 2030, showing a compound annual growth rate (CAGR) of 12.6%. Factors contributing to this growth over the forecast period include the expanding acceptance of personalized medicine strategies, a greater need for identifying diseases at early stages, the broadening scope of newborn screening requirements, increased funding into genomics infrastructure, and the heightened utilization of digital health platforms. Key trends during this period are expected to feature the wider uptake of non-invasive prenatal testing, an increase in the application of sophisticated genetic screening panels, the growing incorporation of AI into genetic risk assessments, the expansion of high-throughput sequencing technologies, and a sharper emphasis on the early identification of congenital conditions.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13158&type=smp
What Factors Are Contributing To The Growth Of The Prenatal And Newborn Genetic Testing Market?
The growing frequency of genetic disorders is anticipated to stimulate the expansion of the prenatal and newborn genetic testing market in the future. Genetic disorders are defined as health conditions arising from irregularities or changes within an individual’s DNA or genetic makeup. These tests allow for the early detection of genetic disorders, frequently prior to symptom onset, thereby empowering healthcare professionals to implement prompt interventions and therapeutic plans. As an illustration, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported in May 2024 that sickle cell disease (SCD) impacts approximately 100,000 individuals in the United States. Of those impacted, over 90% are non-Hispanic Black or African American, with an estimated 3%-9% being Hispanic or Latino. Consequently, the expanding commonness of genetic disorders acts as a driver for the prenatal and newborn genetic testing market.
How Is The Prenatal And Newborn Genetic Testing Market Organized By Segment Classification?
The prenatal and newborn genetic testing market covered in this report is segmented –
1) By Product Type: Consumables, Instruments
2) By Screening: Non-Invasive Prenatal Testing, Chronic Villus Sampling, Amniocentesis, Maternal Serum Screening, Other Screenings
3) By Disease: Down Syndrome, Phenylketonuria, Cystic Fibrosis, Sickle Cell Anemia
4) By End User: Hospital, Maternity And Specialty Clinics, Diagnostic Centers
Subsegments:
1) By Consumables: Reagents And Assays, Sample Collection Kits, Test Kits
2) By Instruments: Polymerase Chain Reaction (PCR) Machines, Sequencers, Microarray Analyzers
What Trends Are Shaping The Future Of The Prenatal And Newborn Genetic Testing Market?
Leading companies within the prenatal and newborn genetic testing markets are focused on developing cutting-edge screening tests, such as noninvasive prenatal screening tests, designed for enhanced accessibility and affordability to deliver dependable services to consumers. Noninvasive prenatal screening (NIPS), also known as noninvasive prenatal testing (NIPT), is a highly sophisticated and secure genetic screening method conducted during pregnancy to evaluate the risk of specific fetal chromosomal abnormalities. For instance, in January 2024, Natera, Inc., a genetic testing company headquartered in the US, introduced a fetal RhD NIPT to determine fetal RhD status, thereby assisting obstetricians in managing patient care during widespread Rho(D) immune globulin (RhIg) shortages. This test is supported by a significant clinical validation study involving over 650 RhD-negative patients with confirmed outcomes, achieving 100% sensitivity and >99% specificity. Natera’s test can be administered early in pregnancy, enabling timely clinical decisions and improving patient management.
Who Are The Industry Participants Involved In The Prenatal And Newborn Genetic Testing Market?
Major companies operating in the prenatal and newborn genetic testing market are F Hoffmann La Roche AG, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson And Company, Quest Diagnostic Incorporated, Agilent Technologies Inc, Illumina Inc, PerkinElmer Genomics, Quidel Corporation, Bio Rad Laboratories Inc, Qiagen NV, Werfen SA, DiaSorin SpA, BGI Group, Natera Inc, Trinity Biotech plc, Meridian Bioscience Inc, Sekisui Diagnostics, Ariosa Diagnostics Inc, AccuBioTech Co Ltd, Sequenom Inc, Roche Diagnostics International AG
Get The Full Prenatal And Newborn Genetic Testing Market Report:
Which Region Dominates The Prenatal And Newborn Genetic Testing Market By Market Share?
North America was the largest region in the prenatal and newborn genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prenatal and newborn genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Prenatal And Newborn Genetic Testing Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Prenatal And Newborn Genetic Testing Market 2026, By The Business Research Company
Infertility Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/infertility-treatment-global-market-report
Precocious Puberty Treatment Market Report
https://www.thebusinessresearchcompany.com/report/precocious-puberty-treatment-global-market-report
Fertility Treatments Market Report
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model